Capecitabine (UK): patient-friendly guide

Capecitabine is an anti-cancer medicine used to treat certain types of cancer. It is a tablet treatment that your body converts into an active drug mainly within tumour tissue. This helps target cancer cells while allowing controlled exposure to healthy tissues.

This page explains how capecitabine works, what it’s used for, how it is typically taken, key safety information, and practical guidance for everyday use in the United Kingdom.

1) Basic product information

Brand names can vary. Your pharmacist or care team can confirm the exact product you have and its tablet strength(s). Always check the label for your specific dose.

2) What capecitabine does (mechanism of action)

Capecitabine is designed to become active after it is absorbed. First, it is converted in the body through several steps into 5-fluorouracil (5-FU). Cancer cells often contain higher levels of the enzymes needed for this conversion, which is why capecitabine can be considered a targeted prodrug.

The active drug interferes with how cells build and repair DNA. This slows down and can stop tumour cell growth, particularly during phases where cells are actively dividing.

Key points

• Prodrug: becomes active largely after conversion inside the body.
• Targets cell division: disrupts DNA/RNA processing in rapidly dividing cells.
• Oral form: taken at home according to a cycle schedule.

3) Pharmacokinetics (how the body handles it)

Pharmacokinetics describes how medicine is absorbed, distributed, metabolised, and eliminated. For capecitabine, the main practical implications are timing, consistency with meals, and monitoring in people who may have reduced kidney or liver function.

• Absorption: capecitabine is absorbed from the gut after swallowing tablets.
• Conversion to active metabolites: occurs stepwise, producing 5-FU.
• Distribution: active metabolites spread through body tissues.
• Metabolism & elimination: metabolites are processed mainly in the liver and excreted via the kidneys and urine.

Because clearance involves the kidneys, reduced kidney function can increase drug exposure and may raise the risk of side effects. This is why kidney monitoring is important during treatment.

4) Typical uses and indications in the UK

Capecitabine is used for several cancer types, often as part of combination therapy or as an alternative treatment option depending on the individual’s situation and cancer stage.

In the UK, capecitabine may be used in clinical settings for cancers such as:

• Breast cancer (for example, certain stages and combinations used according to treatment plans).
• Colon cancer (including adjuvant treatment after surgery in some circumstances).
• Rectal cancer (in some protocols, sometimes alongside radiotherapy in practice).
• Gastric cancer (in specific regimens depending on local guidance and eligibility).
• Oesophago-gastric/upper GI cancers (where protocols support capecitabine-based approaches).

Indications can depend on national and specialist guidance, and on whether capecitabine is used alone or in combination with other medicines. Your oncology team will confirm the intended purpose for your situation.

5) How to take capecitabine: timing, cycle patterns, and practical instructions

Capecitabine is usually taken in cycles (a period of taking tablets followed by a break). The exact pattern depends on the treatment plan and cancer type.

Common schedule (example)

A frequently used approach is:

• 14 days of tablets
• 7 days off

This is often repeated in cycles. However, your specific schedule may differ. Always follow your treatment plan exactly as written on your dispensing label and by your clinical team.

Timing with meals

Capecitabine is generally taken within 30 minutes after food (meals). Food helps absorption and can reduce gastrointestinal side effects.

• Take your morning dose after breakfast (within 30 minutes).
• Take your evening dose after dinner (within 30 minutes).
• Try to take doses at consistent times each day.

Swallowing and handling tablets

• Swallow tablets whole with water. Do not crush or chew unless your clinical team instructs otherwise.
• Wash hands after handling tablets (and keep them out of reach of children).
• If tablets are broken or damaged, avoid direct contact and ask your pharmacist for advice.
• Keep a record of doses taken if it helps you stay consistent.

If you miss a dose

Missing doses can affect treatment effectiveness. Follow the guidance provided with your medicine or by your clinical team. In many chemotherapy regimens, the general principle is not to take extra tablets to compensate.

Because instructions can vary by cycle schedule and dose modification rules, the safest option is to contact your oncology/haemato-oncology team or pharmacist for personalised advice if you miss a dose.

6) Food interactions and dietary considerations

The most important food-related instruction for capecitabine is that it is typically taken after meals. This improves how the body absorbs the medicine.

Practical meal tips

• Take with food: Aim for within 30 minutes of a meal.
• Keep meal timing steady: sudden changes in meal schedule can make it harder to take the dose correctly.
• Manage nausea: small, frequent meals and bland foods may help if you experience indigestion.
• Stay hydrated: unless you have fluid restrictions for another reason.

Grapefruit and certain supplements

Some foods and supplements may affect drug metabolism. While capecitabine’s most critical requirement is “take after food,” it is still advisable to discuss:

• Herbal remedies and high-dose supplements (including vitamin and plant extracts)
• Grapefruit products or unusual diets

with your pharmacist or clinical team to ensure there are no concerns for your specific regimen.

7) Alcohol and medicine interactions

Alcohol can worsen side effects such as nausea, fatigue, dehydration, and may affect liver function. Because capecitabine can also impact the liver and gut, it’s best to be cautious.

Alcohol guidance (general)

• Ask your clinical team whether alcohol is safe for you personally.
• If you drink alcohol, do so sparingly and avoid binge drinking.
• Stop drinking and contact your team if you develop significant vomiting, severe diarrhoea, or unusual yellowing of the skin/eyes.

Potential medicine interactions

Capecitabine can interact with other medicines, including those that affect:

• Blood thinning and bleeding risk
• Immune system effects
• Kidney or liver function
• Drug metabolism pathways

It is especially important to tell your pharmacist or clinical team if you take:

• Warfarin or other anticoagulants
• Phenytoin (for seizures)
• Folinic acid and other combination chemotherapy agents (where relevant)
• Allopurinol
• Medicines that reduce stomach acid or treat ulcers (discuss specifics)
• Over-the-counter remedies such as anti-inflammatory medicines (NSAIDs), anti-diarrhoeal products, or strong supplements

Always provide a complete list of medicines (including herbal products and vitamins) to your pharmacist. Interaction checks are part of safe dispensing.

8) Dosing: understanding your dose and dose adjustments

Capecitabine dosing is commonly calculated based on body size, such as body surface area (BSA), and adjusted for kidney function, age, and treatment tolerance. The exact regimen and tablet strengths can vary by indication and by your treatment plan.

Why dose may change

• Side effects (for example, hand-foot syndrome, diarrhoea, low blood counts)
• Reduced kidney function
• Infections or other complications
• Drug combinations used in your protocol

If side effects occur, clinicians may temporarily stop treatment, reduce the dose, or adjust the schedule. This is not unusual and is part of managing safety.

Do not change your dose yourself

If you feel unwell, it can be tempting to reduce tablets. Avoid changing the dose unless your clinical team instructs you. Getting the dosing right helps balance effectiveness and safety.

9) Safety profile: common and serious side effects

Like all cancer medicines, capecitabine can cause side effects. Many are manageable with supportive care, while others require urgent medical attention.

Common side effects

• Diarrhoea (may range from mild to severe)
• Nausea and upset stomach
• Vomiting
• Fatigue and weakness
• Decreased appetite
• Inflammation of the mouth (mouth ulcers, soreness)
• Hand-foot syndrome (redness, pain, swelling, skin peeling on hands/feet)
• Skin changes or dryness
• Low blood counts (increased infection risk and tiredness)

Serious or urgent symptoms

Seek urgent advice if you experience any of the following:

• Severe diarrhoea or diarrhoea that does not improve quickly
• Signs of infection (fever, chills, feeling very unwell)
• Severe mouth sores preventing drinking
• Dehydration (dizziness, very dry mouth, reduced urination)
• Breathing problems or swelling of the face/lips (possible allergic reaction)
• Severe hand-foot syndrome affecting movement or daily activities

Monitoring during treatment

Regular blood tests are typically performed to check:

• Blood counts
• Kidney function
• Liver function

Monitoring helps determine whether dose adjustments are needed.

10) Practical use tips for everyday life

Preventing or reducing hand-foot syndrome

• Keep hands and feet moisturised using an appropriate emollient.
• Avoid friction: wear comfortable, well-fitting shoes.
• Avoid heat exposure: hot baths, hot tubs, and heating pads may worsen symptoms.
• Report early symptoms (tingling, redness, tenderness) so clinicians can advise dose modifications.

Managing diarrhoea

• Start early supportive care as instructed by your care team.
• Maintain hydration: small sips frequently can help.
• Avoid foods that seem to worsen symptoms (for example, very spicy foods).
• Contact your team promptly for moderate to severe diarrhoea.

Oral care for mouth soreness

• Use a soft toothbrush and gentle rinses.
• Avoid alcohol-containing mouthwash if it irritates your mouth.
• Tell your team early if swallowing becomes painful.

Energy and wellbeing

• Plan rest periods during treatment cycles.
• Light activity (such as short walks) may help some people, if appropriate for your condition.
• Seek advice for sleep problems or mood changes.

11) Alternative options and related medicines

Depending on your cancer type, stage, and prior treatment, alternative options may include other chemotherapy agents or targeted treatments. Capecitabine may be used instead of intravenous fluorouracil in some protocols, or as part of combination regimens.

Potential alternatives (to be discussed with your specialist) can include:

• 5-fluorouracil (5-FU) (intravenous) in some regimens
• Other oral fluoropyrimidines used in certain cancers
• Targeted therapies depending on tumour markers
• Immunotherapy in eligible cancers
• Different chemotherapy schedules (e.g., irinotecan- or oxaliplatin-based regimens), based on clinical need

Your oncology team will choose the best option by considering effectiveness, expected side effects, and your overall health.

12) UK market and legal context (supply, regulation, and guidance)

In the United Kingdom, medicines are regulated and governed by medicines law and safety monitoring systems. Capecitabine is available through appropriate healthcare channels in line with local prescribing and dispensing requirements.

Patient safety information, including product characteristics and updates to use, is supported by:

• Medicines regulatory guidance (including the UK medicines framework)
• Safety monitoring such as the Yellow Card scheme for suspected adverse reactions
• Specialist cancer guidelines used by oncology teams

If you are taking capecitabine, you may have guidance tailored to your protocol. It’s important to keep up with changes communicated by your healthcare provider or cancer team.

Recent guidance (what to expect)

Recent practice trends often focus on:

• Early recognition and prompt management of diarrhoea, infections, and hand-foot syndrome
• Appropriate dose modifications to improve tolerability
• Closer monitoring for people with kidney impairment or other comorbidities
• Medication reconciliation to reduce interaction risks

Your healthcare team can confirm the exact approach used for your regimen.

13) Delivery and availability in the United Kingdom

Capecitabine availability can vary by strength and pack size depending on manufacturer supply and pharmacy stock. In the UK, pharmacies may order medicines in when not immediately available. Availability may also depend on seasonal or manufacturing schedules.

Delivery expectations

• Dispatch: timing depends on stock status and ordering processes.
• Packaging: medicines are shipped securely to protect tablets and follow safe handling requirements.
• Tracking: some deliveries may offer tracking or confirmation of drop-off.
• Storage: follow the label instructions for storage (typically room temperature unless stated otherwise).

If you have time-critical treatment dates, it’s helpful to place orders early and allow extra time for dispatch and courier delivery.

If you need urgent advice about urgent supply, contact your pharmacy or your cancer team for the safest next step.

14) FAQs

Can I take capecitabine with food?

Yes—capecitabine is typically taken after meals (often within 30 minutes). This helps absorption and can reduce stomach side effects. Always follow your specific instructions.

What should I do if I vomit after taking capecitabine?

Do not automatically take an extra dose. Contact your pharmacist or clinical team for advice, as whether to repeat a dose can depend on timing and your treatment schedule.

How long does a treatment cycle last?

Cycles vary by indication. A commonly used pattern is 14 days on treatment followed by 7 days off, but your schedule may differ. Check your dispensing label and treatment plan.

Is it safe to drive while taking capecitabine?

Many people are able to drive, but side effects such as fatigue, dizziness, or blurred vision can occur. If you feel unwell, avoid driving and seek advice.

What is hand-foot syndrome and when should I worry?

Hand-foot syndrome is a reaction that affects the skin of the hands and feet, causing redness, pain, swelling, or peeling. Report symptoms early. Seek urgent advice if pain is severe, skin breaks down, or you struggle with everyday activities.

Can I take capecitabine if I have kidney problems?

Kidney function influences how capecitabine is cleared. Your care team may adjust the dose or schedule and will monitor blood tests more closely. Do not change dosing without clinical guidance.

Do I need to avoid certain medicines?

Interaction risk exists with several medicines, including some blood thinners and seizure medicines. Always share your full list of medicines (including over-the-counter and herbal products) with your pharmacist for a safe check.

Can I drink alcohol during treatment?

Alcohol may worsen side effects and affect liver health. It’s best to discuss alcohol use with your clinical team. If permitted, keep it minimal and avoid binge drinking.

Are there alternative treatments if capecitabine doesn’t suit me?

Yes. Depending on the cancer type and stage, clinicians may consider other chemotherapy options, targeted therapies, immunotherapy, or different regimens. Your specialist can discuss what fits your situation.

How should I store capecitabine at home?

Store tablets according to the instructions on the packaging. Keep them out of the sight and reach of children. Avoid storing in areas with excessive heat or moisture unless stated otherwise.

Important note

This information is intended to help you understand capecitabine in a general, patient-friendly way. Individual dosing, timing, and safety advice can vary based on your cancer type, other treatments, and health status. If you are unsure about any part of your treatment, speak to your healthcare professional or pharmacist.